Personalised Medicine

Personalised Medicine Viewer

Chemo before surgery benefits patients with advanced ovarian cancer

Publication date:

Chemotherapy machine

Women with advanced ovarian cancer have fewer side effects and tend to have a better quality of life if given chemotherapy before surgery, according to a Cancer Research UK funded study published in The Lancet.

Smoking induces early signs of cancer in cheek swabs

Publication date:

Ashtray

DNA damage caused by smoking can be detected in cheek swabs, finds research published today in JAMA Oncology. The study provides evidence that smoking induces a general cancer program that is also present in cancers which aren’t usually associated with it – including breast and gynaecological cancers.

New test could identify resistant tuberculosis faster in London

Publication date:

Mycobacterium tuberculosis

Tuberculosis (TB) disease rates in some parts of London are as high as in Sub-Saharan Africa, and drug-resistant strains are becoming increasingly common. These require specific treatments, and if doctors know that a bug is resistant they can start therapy earlier, often leading to better outcomes.

New screening technique could pick up twice as many ovarian cancer cases

Publication date:

Ovarian cancer under the microscope

A new screening method can detect twice as many women with ovarian cancer as conventional strategies, according to the latest results from the largest trial of its kind led by UCL.

Human immune system can control re-awakened HIV, suggesting ‘kick and kill’ cure is possible

Publication date:

Scanning electromicrograph of an HIV-infected H9 T cell

The human immune system can handle large bursts of HIV activity and so it should be possible to cure HIV with a ‘kick and kill’ strategy, finds new research led by UCL, University College London Hospitals (UCLH) NHS Foundation Trust, the University of Oxford and the University of North Carolina at Chapel Hill.

New role uncovered for ‘oldest’ tumour suppressor gene

Publication date:

Professor Sibylle Mittnacht interviewed by Clare Hastings at The Institute of Cancer Research, London

Scientists have revealed a brand new function for one of the first cancer genes ever discovered – the retinoblastoma gene – in a finding that could open up exciting new approaches to treatment.

Weight discrimination has major impact on quality of life

Publication date:

Man on scales

Weight discrimination is linked to significantly lower quality of life, and accounts for approximately 40% of the negative psychological effects associated with obesity, finds new UCL research funded by Cancer Research UK.

The first fine-scale genetic map of the British Isles

Publication date:

The regions of ancient British, Irish and Saxon control in the 7th Century

Many people in the UK feel a strong sense of regional identity, and it now appears that there may be a scientific basis to this feeling, according to a landmark new study into the genetic makeup of the British Isles.

Cancer fear can impact screening uptake

Publication date:

Colorectal cancer tumour

People who worry about cancer are more likely to want to get screened for colon cancer, but feeling uncomfortable at the thought of cancer makes them less likely to actually go for the test, finds new UCL-led research.

£14M to develop HIV self-testing in southern Africa

Publication date:

Clinic

A partnership involving UCL has been awarded £14M to accelerate access to simple self-tests in African countries. Self-testing for HIV using rapid diagnostic kits is becoming increasingly widely used, allowing high-risk people to test their own HIV status in private.

Family history screening misses people at high risk of cancer

Publication date:

Eve Appeal

UCL research into the BRCA gene mutation in the Jewish population show that only assessing family history misses half of the people with the mutation.

Secret of tetanus toxicity offers new way to treat motor neuron disease

Publication date:

Image showing how tetanus neurotoxin (red) binds to areas rich in nidogen-2 (green)

The way that tetanus neurotoxin enters nerve cells has been discovered by UCL scientists, who showed that this process can be blocked, offering a potential therapeutic intervention for tetanus. This newly-discovered pathway could be exploited to deliver therapies to the nervous system, opening up a whole new way to treat neurological disorders such as motor neuron disease and peripheral neuropathies.

UCL awarded £4.2 million for stem cell transplantation and immunotherapy

Publication date:

Blood for transplant

UCL has been awarded £4.2 million from the National Institute for Health Research (NIHR) to fund a Blood and Transplant Research Unit for stem cell transplantation and immunotherapy, due to launch in October 2015.

UCL awarded £13.5 million to advance medical research facilities

Publication date:

UCL Quad

As part of the Clinical Research Infrastructure Initiative, UCL has been awarded £13.5 million for a number of projects to help advance clinical research.

Simplifying TB treatments to improve patients’ lives

Publication date:

Mycobacterium tuberculosis

Ways to simplify treatments for tuberculosis (TB) to reduce drug resistance and make it easier for patients to complete their course of treatment have been trialled by two international groups involving UCL scientists.

People with diabetes are less able to regulate the body’s responses to stress

Publication date:

Stress

People with type 2 diabetes are physically less able to recover from stress, finds a study by scientists at UCL and the University of Zurich, funded by the British Heart Foundation.

UCL research helps paralysed man to recover function

Publication date:

Professor Geoff Raisman

A man who was paralysed from the chest down following a knife attack can now walk using a frame, following a pioneering cell transplantation treatment developed by scientists at UCL and applied by surgeons at Wroclaw University Hospital, Poland.

Gene variant that dramatically reduces ‘bad’ lipids

Publication date:

DNA helix

Research using data collected from around 4,000 healthy people in the UK has enabled scientists from UCL, the Wellcome Trust Sanger Institute and the University of Bristol  to identify a rare genetic variant that dramatically reduces levels of certain types of lipids in the blood.

Gene variant linked to schizophrenia, bipolar disorder and alcoholism

Publication date:

Depression

A rare gene variant discovered by UCL scientists is associated with an increased risk of developing schizophrenia, bipolar disorder and alcoholism, confirms new research.

Pre-diabetes label ‘unhelpful and unnecessary’

Publication date:

Blood tests are used to check for type 2 diabetes

Labelling people with moderately high blood sugar as pre-diabetic is a drastically premature measure with no medical value and huge financial and social costs, say researchers from UCL and the Mayo Clinic, Minnesota.

Working with Camden Council to get children active

Publication date:

Camden Active Spaces playground design for Torriano Infants and Junior School

An initiative to see if playground design can inspire schoolchildren to be more active, Camden Active Spaces, is launched today at the Institute of Sport Exercise and Health (ISEH) in partnership with UCL and Camden Council.

Diabetes treatments ‘do more harm than good’ for many people

Publication date:

Insulin injections for people with type 2 diabetes may cause more harm than good

Treatments to reduce blood sugar levels do more harm than good in many type 2 diabetes patients, particularly older people, finds new research from UCL, the University of Michigan and the Ann Arbor Veterans Affairs Hospital.

New test predicts the risk of non-hereditary breast cancer

Publication date:

Professor Martin Widschwendter

A simple blood test is currently in development that could help predict the likelihood of a woman developing breast cancer, even in the absence of a high-risk BRCA1 gene mutation, according to new UCL research.

Leukaemia drug found to stimulate immunity against many cancer types

Publication date:

Mice without p110delta survived cancer significantly longer

A class of drug currently being used to treat leukaemia has the unexpected side-effect of boosting immune responses against many different cancers, reports a new study led by scientists at UCL and the Babraham Institute, Cambridge.

‘Map of pain’ reveals how our ability to identify the source of pain varies across the body

Publication date:

Demonstration of spatial acuity test

“Where does it hurt?” is the first question asked to any person in pain.

A new UCL study defines for the first time how our ability to identify where it hurts, called “spatial acuity”, varies across the body, being most sensitive at the forehead and fingertips.

Search UCL News